Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors
Journal of the American College of Cardiology · 2023-09 · 82 (13) · 1343-1359
DOI: 10.1016/j.jacc.2023.06.045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American College of Cardiology, 2023-09. Verfasst von Gemma A Figtree und 42 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; Cardiovascular Discovery Group, Koll…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Myocardial Infarction, Atherosclerosis. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: British Heart Foundation, NHLBI NIH HHS.
Abstract (Originalsprache)
Reducing the incidence and prevalence of standard modifiable cardiovascular risk factors (SMuRFs) is critical to tackling the global burden of coronary artery disease (CAD). However, a substantial number of individuals develop coronary atherosclerosis despite no SMuRFs. SMuRFless patients presenting with myocardial infarction have been observed to have an unexpected higher early mortality compared to their counterparts with at least 1 SMuRF. Evidence for optimal management of these patients is lacking. We assembled an international, multidisciplinary team to develop an evidence-based clinical pathway for SMuRFless CAD patients. A modified Delphi method was applied. The resulting pathway confirms underlying atherosclerosis and true SMuRFless status, ensures evidence-based secondary prevention, and considers additional tests and interventions for less typical contributors. This dedicated pathway for a previously overlooked CAD population, with an accompanying registry, aims to improve outcomes through enhanced adherence to evidence-based secondary prevention and additional diagnosis of modifiable risk factors observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; Cardiovascular Discovery Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Austr…
- Department of Cardiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; The George Institute for Global Health, Faculty of Medicine, UNSW, Sydney, New South Wales, Australia.
- The George Institute for Global Health, Faculty of Medicine, UNSW, Sydney, New South Wales, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
- Consumer Representative, Agile Group Switzerland AG, Zug, Switzerland.
- Department of Cardiology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
- National Centre for Indigenous Genomics, Australian National University, Canberra, Australian Capitol Territory, Australia; Telethon Kids Institute, Nedlands, Western Australia, Australia.
Förderung
- British Heart Foundation
- NHLBI NIH HHS
Zitieren
APA
Figtree, G. A., Vernon, S. T., Harmer, J. A., Gray, M. P., Arnott, C., Bachour, E., Barsha, G., Brieger, D., Brown, A., Celermajer, D. S., Channon, K. M., Chew, N. W. S., Chong, J. J. H., Chow, C. K., Cistulli, P. A., Ellinor, P. T., Grieve, S. M., Guzik, T. J., Hagström, E., …, & CRE for CAD Collaborators (2023). Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors. Journal of the American College of Cardiology, 82(13), 1343-1359. https://doi.org/10.1016/j.jacc.2023.06.045
Vancouver
Figtree GA, Vernon ST, Harmer JA, Gray MP, Arnott C, Bachour E, et al. Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors. Journal of the American College of Cardiology. 2023;82(13):1343-1359. doi:10.1016/j.jacc.2023.06.045
BibTeX
@article{Figtree2023,
author = {Figtree, Gemma A and Vernon, Stephen T and Harmer, Jason A and Gray, Michael P and Arnott, Clare and Bachour, Eric and Barsha, Giannie and Brieger, David and Brown, Alex and Celermajer, David S and Channon, Keith M and Chew, Nicholas W S and Chong, James J H and Chow, Clara K and Cistulli, Peter A and Ellinor, Patrick T and Grieve, Stuart M and Guzik, Tomasz J and Hagström, Emil and Jenkins, Alicia and Jennings, Garry and Keech, Anthony C and Kott, Katharine A and Kritharides, Leonard and Mamas, Mamas A and Mehran, Roxana and Meikle, Peter J and Natarajan, Pradeep and Negishi, Kazuaki and O'Sullivan, John and Patel, Sanjay and Psaltis, Peter J and Redfern, Julie and Steg, Philippe G and Sullivan, David R and Sundström, Johan and Vogel, Birgit and Wilson, Andrew and Wong, Dennis and Bhatt, Deepak L and Kovacic, Jason C and Nicholls, Stephen J and CRE for CAD Collaborators, CRE for CAD Collaborators},
title = {Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors},
journal = {Journal of the American College of Cardiology},
year = {2023},
volume = {82},
number = {13},
pages = {1343--1359},
doi = {10.1016/j.jacc.2023.06.045}
}
EUVIMED